# Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)

> **NCT06157502** · PHASE3 · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 1380 (estimated)

## Conditions studied

- Ischemic Stroke, Acute

## Interventions

- **DRUG:** Shuxuening Injection
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06157502
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-11
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 1380 (ESTIMATED)
- **Last updated:** 2025-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06157502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06157502, "Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06157502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*